Recent News News Blog Press Releases In the News Featured News Publications Contact Us Press Release Apr. 1, 2020 The Wistar Institute Signs Lease at 3.0 University Place Signed lease agreement of up to 10 years for 8,000 sf with options for additional space to support long-term needs. In addition to their own Wistar Discovery Center lab space, Wistar will launch… Blog Post Mar. 23, 2020 Wistar Translational Research in Response to the COVID-19 Pandemic The Wistar Institute’s Vaccine & Immunotherapy Center (VIC) has assembled its expertise in infectious disease research, as its scientists are part of a team racing to provide a countermeasure… Featured News Mar. 18, 2020 Wistar Expands Its Training Program With Support From the PA Depar... On March 12, the Pennsylvania Department of Labor & Industry (L&I) announced more than $6.5 million in PAsmart Registered Apprenticeship Grants. Press Release Mar. 11, 2020 Coupling Computational Protein Engineering with DNA Technology Synthetic DNA technology allows for in vivo assembly of complex nanovaccines able to elicit stronger immune responses in preclinical studies Blog Post Mar. 11, 2020 Coming of Age: The Creation of the HPV Vaccine Human papillomavirus (HPV) is the most commonly sexually transmitted virus in the world, infecting 75% of sexually active adults in their lifetime1. Blog Post Mar. 4, 2020 A New Generation of Cancer Researchers at Wistar A conversation with the latest Cancer Center additions Blog Post Feb. 26, 2020 Vaccination Exploration: The Case of Measles, Mumps and Rubella Getting sick with these childhood diseases could mean much more than a fever and a rash. Blog Post Feb. 26, 2020 Women & Science: Becoming a Leader and a Role Model At the latest installment of Wistar’s Women & Science Program, guest speaker Dr. Padmanee Sharma, a distinguished clinician and researcher who has focused her career on understanding how to… Blog Post Feb. 19, 2020 Wistar Science Highlights: Advances in Ovarian Cancer Research and... New combination therapy approach for ovarian cancer and discovery of a mechanism involved in response to immunotherapy in the disease; role of p53 genetic variant in iron accumulation and immune… Press Release Feb. 19, 2020 New Mechanism Modulates Inflammation, Immunotherapy Response The newly identified pathway may be modulated during chemotherapy to enable response to immune checkpoint blockade Featured News Feb. 4, 2020 The World Is a Lot Smaller Than You Think Nikon Small World opening night brought to Wistar a crowd of science and art enthusiasts to marvel at the beautiful images of 2019 and listen to first-place winners talk about the work behind… Press Release Jan. 30, 2020 Novel Combination Strategy to Expand PARP Inhibitors for Ovarian C... EZH2 inhibitors sensitize cancer cells that are intrinsically resistant to PARP inhibitors. Communications In the News Check out some of the recent media coverage Wistar and its scientists have received. Publications View our Annual Report, Focus magazine and sign-up for our monthly e-newsletter. Media Inquiries If you are a member of the media and would like to speak with a Wistar scientists on any matter, please contact our Communications and Marketing Department.
